Dentists in Crest Hill, IL Accepting Medicare
23 Dentists found. Showing 1 - 20
 Ahmed Shareef, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1701 N Larkin Ave, Crest Hill, IL 60403 Phone: 815-741-9900 |
Thomas Barrett Braun, D.D.S. Dentist - Periodontics Medicare: Medicare Enrolled Practice Location: 2312 Plainfield Rd., Crest Hill, IL 60403 Phone: 815-744-7175 |
Dr. Daniel Pagel, DMD Dentist - Dental Public Health Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-741-1700 |
 Dr. Mojdeh Foroohar, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2312 Plainfield Rd., Crest Hill, IL 60403 Phone: 815-729-9668 |
Dr. Sirisha Mandadi, DDS Dentist - Prosthodontics Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-741-1700 Fax: 815-741-8511 |
Dr. Oleksandr Grechko, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2241 Theodore Street, Crest Hill, IL 60403 Phone: 815-741-1700 |
Dr. Russell Martin Verbic, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-741-1700 |
Glenn Jon Zimmer, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore St, Crest Hill, IL 60435 Phone: 815-741-1700 |
Gaith Khatlan, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-741-1700 |
Ken Arrieta, DDS Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore, Crest Hill, IL 60403 Phone: 815-741-1700 Fax: 815-741-8511 |
Dr. Lisa Lynn Worthley, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore St, Crest Hill, IL 60435 Phone: 815-741-1700 Fax: 815-741-8511 |
Dr. Carlla Duster Franklin, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2241 Theodore Street, Crest Hill, IL 60432 Phone: 815-741-1700 |
Dr. Anthony D. Varchetto, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-741-1700 |
Dr. Isha B Bassi, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-546-4269 |
Dr. Scott Dennis Beallis, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2312 Plainfield Rd., Crest Hill, IL 60403 Phone: 815-729-9668 Fax: 815-729-1521 |
Dr. Thomas John Raia, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2410 Caton Farm Road, Suite C, Crest Hill, IL 60403 Phone: 815-439-1111 Fax: 815-439-9709 |
Mr. David Joseph Rubis, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2241 Theodore St, Crest Hill, IL 60435 Phone: 815-741-1700 |
Dr. Michael Vincent Guadiz, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-741-1700 |
Dr. Samia Khan, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-741-1700 |
Dr. Jun Hyeok Choi, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2241 Theodore St, Crest Hill, IL 60403 Phone: 815-741-1700 |
News Archive
Genetic mutation linked to peripheral artery disease
The finding, appearing online in the journal Circulation, is the first to document a genetic mutation linked to PAD. Although the work was done in mice, researchers say it is likely to give them new insight into how PAD develops and progresses in humans.
OncoGenex initiates Phase 3 Prostate Cancer SATURN Trial
OncoGenex Pharmaceuticals, Inc. announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries to develop and commercialize OGX-011/ TV-1011.
Dialysis patients panic as financial ‘life raft' becomes unmoored
Russell Desmond received a letter a few weeks ago from the American Kidney Fund that he said felt like "a smack on the face."
Adolor commences clinical testing of its oral mu opioid receptor antagonist
Adolor Corporation today announced the initiation of clinical testing of ADL7445, its proprietary, oral mu opioid receptor antagonist for the treatment of Opioid Bowel Dysfunction (OBD). The Phase 1, single ascending dose trial in healthy volunteers will assess safety and tolerability of the compound and will be followed by a multiple ascending dose study in early 2010.
› Verified 7 days ago
- 1(current)
- 2
Counselors
Dentists
Pharmacists
Occupational Therapists
Clinical Social Workers